| Description | ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and
compounds in the United States. It operates through two segments: Diagnostic Services
and Consumer Products. The company provides a range of dietary supplements under
the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge
XL, an energy and stamina booster. It also develops BE-Smart Esophageal Pre-Cancer
diagnostics screening test for early detection of esophageal cancer; genomics testing
technologies to analyze entire genomes, including the genes and chromosomes in deoxyribonucleic acid; DNA Expand, a platform that allows consumers to upload their
DNA data from previous DNA tests obtained from other service providers; and LB-1
and LB-2 for the treatment of cancer, inflammatory diseases or symptoms and memory
related syndromes, diseases or symptoms, including dementia and Alzheimers disease.
In addition, the company provides a broad range of COVID-19 related clinical diagnostic
and testing services, comprising PCR testing for COVID-19, and Influenza A and B, as
well as rapid antigen testing for COVID-19. It offers its genome sequencing products to
consumers online with plans to sell in food, drug, and mass retail stores.
Additional info from NASDAQ:
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.
Additional info from OTC:
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and
compounds in the United States. It operates through two segments: Diagnostic Services
and Consumer Products. The company provides a range of dietary supplements under
the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge
XL, an energy and stamina booster. It also develops BE-Smart Esophageal Pre-Cancer
diagnostics screening test for early detection of esophageal cancer; genomics testing
technologies to analyze entire genomes, including the genes and chromosomes in deoxyribonucleic acid; DNA Expand, a platform that allows consumers to upload their
DNA data from previous DNA tests obtained from other service providers; and LB-1
and LB-2 for the treatment of cancer, inflammatory diseases or symptoms and memory
related syndromes, diseases or symptoms, including dementia and Alzheimers disease.
In addition, the company provides a broad range of COVID-19 related clinical diagnostic
and testing services, comprising PCR testing for COVID-19, and Influenza A and B, as
well as rapid antigen testing for COVID-19. It offers its genome sequencing products to
consumers online with plans to sell in food, drug, and mass retail stores. |
|---|